VIRITAC, created in 2007 (United States), from 18 sister brands and 2214 competing brands. VIRITAC is owned by Vertex Pharma, listed on the stock exchange of New York The sector of VIRITAC is Biotechnology.
Investment simulator :
Portfolio valuation
Vertex Pharma
(VIRITAC)
over 5 years*
USD 945.78